These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6988134)

  • 1. Maternal administration of glucocorticoids.
    Beck JC; Johnson JW
    Clin Obstet Gynecol; 1980 Mar; 23(1):93-113. PubMed ID: 6988134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fetal lung maturation and the antenatal use of glucocorticoids to prevent the respiratory distress syndrome.
    Shields JR; Resnik R
    Obstet Gynecol Surv; 1979 May; 34(5):343-63. PubMed ID: 379720
    [No Abstract]   [Full Text] [Related]  

  • 3. [Glucocorticoids and the respiratory distress syndrome in the newborn. A review of the literature].
    Gandibleux-Bergiers MF
    J Gynecol Obstet Biol Reprod (Paris); 1982; 11(5):625-37. PubMed ID: 6757311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocorticoids and the respiratory distress syndrome.
    Johnson JW; Beck JC; Haberkern CM
    Obstet Gynecol Annu; 1984; 13():99-129. PubMed ID: 6371622
    [No Abstract]   [Full Text] [Related]  

  • 5. Hormones and lung maturation.
    Ballard PL
    Monogr Endocrinol; 1986; 28():1-354. PubMed ID: 2869406
    [No Abstract]   [Full Text] [Related]  

  • 6. Fetal versus maternal and gestational age effects of repetitive antenatal glucocorticoids.
    Jobe AH; Newnham J; Willet K; Sly P; Ikegami M
    Pediatrics; 1998 Nov; 102(5):1116-25. PubMed ID: 9794943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antenatal glucocorticoid therapy for the prevention of respiratory distress syndrome in the premature infant.
    Block MF; Kling OR; Crosby WM
    Obstet Gynecol; 1977 Aug; 50(2):186-90. PubMed ID: 327364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung morphometry after repetitive antenatal glucocorticoid treatment in preterm sheep.
    Willet KE; Jobe AH; Ikegami M; Kovar J; Sly PD
    Am J Respir Crit Care Med; 2001 May; 163(6):1437-43. PubMed ID: 11371415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intrauterine stimulation for fetal respiratory system maturation; benefits and risks].
    Kinalski M; Sledziewski A; Kretowski A
    Wiad Lek; 2000; 53(9-10):538-45. PubMed ID: 11148922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lung maturation therapy with glucocorticoids in threatened premature labor. Considerations of risk-benefit in evidence-based medicine].
    Sauerwald A; Rath W
    Z Geburtshilfe Neonatol; 2000; 204(6):203-9. PubMed ID: 11199148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surfactant sufficiency for immature infants--prenatal induction vs. postnatal treatment.
    Taeusch HW; Smith BT
    Eur J Respir Dis Suppl; 1987; 153():249-54. PubMed ID: 3480820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Respiratory distress syndrome and the induction of fetal lung maturity by the use of glucocorticoids.
    Jones MB
    JOGN Nurs; 1977; 6(4):21-8. PubMed ID: 587200
    [No Abstract]   [Full Text] [Related]  

  • 13. The use of exogenous maternal glucocorticoids to prevent neonatal respiratory distress syndrome (RDS)--the state of the facts.
    Zachman RD
    Wis Med J; 1976 Sep; 75(9):S91-2. PubMed ID: 969558
    [No Abstract]   [Full Text] [Related]  

  • 14. Effectiveness of antenatal steroids in obstetric subgroups.
    Elimian A; Verma U; Canterino J; Shah J; Visintainer P; Tejani N
    Obstet Gynecol; 1999 Feb; 93(2):174-9. PubMed ID: 9932550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticoid effects in the fetal lung.
    Ballard PL; Benson BJ; Brehier A
    Am Rev Respir Dis; 1977 Jun; 115(6 Pt 2):29-36. PubMed ID: 577381
    [No Abstract]   [Full Text] [Related]  

  • 16. [Dilemmas about the antenatal use of corticosteroids for prevention of neonatal morbidity and mortality].
    Grgić O; Matijević R
    Acta Med Croatica; 2005; 59(2):129-35. PubMed ID: 15909887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of prenatal glucocorticoid therapy to prevent respiratory distress syndrome. A supporting view.
    Ballard RA; Ballard PL
    Am J Dis Child; 1976 Sep; 130(9):982-7. PubMed ID: 961661
    [No Abstract]   [Full Text] [Related]  

  • 18. Combined effects of antenatal corticosteroids and surfactant supplementation on the outcome of very low birth weight infants.
    Modanlou HD; Beharry K; Padilla G; Iriye B
    J Perinatol; 1996; 16(6):422-8; quiz 429-30. PubMed ID: 8979178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of fetal alveolar surfactant: possibility of induction].
    Bracaglia R; Bellati U; Serri F; Garzetti GG
    Clin Ter; 1979 Dec; 91(6):593-606. PubMed ID: 44494
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevention of respiratory distress syndrome: synergistic therapies.
    Gross I
    Mead Johnson Symp Perinat Dev Med; 1988; (33):37-41. PubMed ID: 2485442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.